Patient education: Acne (Beyond the Basics)
- Emmy Graber, MD, MBA
Emmy Graber, MD, MBA
- Clinical Instructor
- Northeastern University
- Section Editors
- Robert P Dellavalle, MD, PhD, MSPH
Robert P Dellavalle, MD, PhD, MSPH
- Section Editor — General Dermatology
- Professor of Dermatology and Public Health
- University of Colorado School of Medicine
- Colorado School of Public Health
- Chief, Dermatology Service
- US Department of Veterans Affairs
- Eastern Colorado Health Care System
- Mark V Dahl, MD
Mark V Dahl, MD
- Section Editor — Acne and Rosacea
- Professor Emeritus
- Mayo Clinic College of Medicine
Acne is a skin condition that causes pimples to develop. Acne is the most common skin disorder in North America, affecting an estimated 85 percent of adolescents.
Effective acne treatments are available to treat existing pimples and prevent new ones from developing. In addition, cosmetic treatments can help to reduce scarring and changes in skin color caused by acne.
HOW DOES ACNE DEVELOP?
There are four basic events involved in the development of acne lesions.
●Hair follicles become blocked with an overabundance of normal skin cells (figure 1). These cells combine with sebum (an oily substance that lubricates the hair and skin), creating a plug in the follicle.
●The glands that produce sebum, known as sebaceous glands, enlarge during adolescence and sebum production increases (figure 2). Numerous sebaceous glands are found on the face, neck, chest, upper back, and upper arms.
●The increase in sebum production allows for the overgrowth of a bacterium called Cutibacterium (formerly Propionibacterium) acnes that normally lives on the skin.
●Inflammation occurs as a result of bacterial overgrowth or other factors (figure 3). This can lead to the rupture of the follicle and the formation of a red or tender pimple.
Hormonal changes — Hormonal changes during adolescence cause the sebaceous glands to become enlarged, and sebum production increases. In most people with acne, hormone levels are normal, but the sebaceous glands are highly sensitive to the hormones.
Less often, women's hormone levels are affected by an underlying medical problem known as polycystic ovary syndrome (PCOS). (See "Patient education: Polycystic ovary syndrome (PCOS) (Beyond the Basics)".)
Acne tends to resolve between ages 30 to 40, although it can persist into or develop for the first time during adulthood. Post-adolescent acne predominantly affects women, in contrast to adolescent acne, which predominantly affects men. Acne can flare before a woman's menstrual period, especially in women older than 30 years.
External factors — Oil-based cosmetics may contribute to the development of acne. Oils and greases in hair products can also worsen skin lesions. Water-based or "non-comedogenic" products are less likely to worsen acne.
People with acne often use soaps and astringents. While these treatments remove sebum from the skin surface, they do not decrease sebum production; frequent or aggressive scrubbing with these agents can actually worsen acne.
Diet — The role of diet in acne is controversial. Some studies have found weak associations between cow's milk and an increased risk of acne, perhaps because of hormones that occur naturally in milk. However, there is no strong evidence that milk, high-fat foods, or chocolate increase the risk of acne.
Stress — Psychological stress can probably worsen acne. In several studies of students, acne severity appeared to worsen during times of increased stress .
There is no single best treatment for acne, and combinations of treatments are sometimes recommended. Since acne lesions take at least eight weeks to mature, you should use a treatment for a minimum of two to three months before deciding if the treatment is effective. (See "Treatment of acne vulgaris".)
Acne skin care — Skin care is an important aspect of acne treatment.
Skin hygiene — Wash your face no more than twice daily using a gentle non-soap facial skin cleanser (eg, Cetaphil, Oil of Olay bar or foaming face wash, or Dove bar) and warm (not hot) water. Some providers recommend avoiding use of a washcloth or loofah, and instead using the hands to wash the face. Vigorous washing or scrubbing can worsen acne and damage the skin's surface.
Do not pick or squeeze pimples because this may worsen acne and cause skin swelling and scarring. It can also cause lesions to become infected.
Moisturizers — Use of a moisturizer minimizes dryness and skin peeling, which are common side effects of some acne treatments. Moisturizers that are labeled as "non-comedogenic" are less likely to block skin pores.
Sun protection — Some acne treatments increase the skin's sensitivity to sunlight (eg, retinoids, doxycycline). To minimize skin damage from the sun, avoid excessive sun exposure and use a sunscreen with SPF 30 or higher that is broad spectrum (blocks both UVA and UVB light) before sun exposure. (See "Patient education: Sunburn prevention (Beyond the Basics)".)
Can I treat my own acne? — If you have mild acne, you can try to treat yourself with non-prescription products initially. Nonprescription acne treatments may include salicylic acid, benzoyl peroxide, sulfur, alpha hydroxy acids, adapalene, or tea tree oil, all of which are available in nonprescription strengths. A combination of these treatments may be more effective than using one single product alone. In rare cases, people have a severe allergic reaction to acne products, so for the first three days, try them on just a small area. (See "Light-based, adjunctive, and other therapies for acne vulgaris".)
If you do not improve after three months of using non-prescription products or you have moderate or severe acne, consult a healthcare provider for advice on the most effective treatments.
Noninflammatory acne — Noninflammatory acne causes whiteheads or blackheads without redness or skin swelling (picture 1).
Retinoids — Topical retinoid medications are often recommended for noninflammatory acne. Examples of these medications include tretinoin (Retin-A, Avita, Atralin) and tazarotene (Tazorac), which require a prescription, and adapalene (Differin), which is available both by prescription and over the counter.
Retinoids are usually applied once per day, although people who develop skin irritation can reduce this to every other day or less, then increase as tolerated over time. Most people become more tolerant of retinoids over time.
Most retinoids are available in a gel or cream. People with oily skin may prefer gels because they have a drying effect, while people with dry skin may prefer a cream.
Retinoids can cause skin irritation. While using topical retinoids, you should apply a sunscreen with SPF 30 or greater before sun exposure.
Other acne products — People who cannot tolerate retinoids may try other topical medications, such as salicylic acid, glycolic acid, or azelaic acid (Azelex, Finacea). All of these treatments can be helpful in reducing noninflammatory acne, and azelaic acid may reduce acne-related darkening of skin.
Mild to moderate inflammatory acne — Mild to moderate acne with some inflammation (picture 2) is usually treated with topical retinoids (see 'Retinoids' above), topical antibiotics, or benzoyl peroxide.
A combination of medications, usually benzoyl peroxide with a topical antibiotic and/or retinoid (eg, tretinoin), is more effective than treatment with one agent alone.
Benzoyl peroxide — Benzoyl peroxide is usually applied twice per day. It may be combined with a topical retinoid, in which case the benzoyl peroxide is applied in the morning and the retinoid is applied at night. Benzoyl peroxide can irritate the skin, sometimes causing redness and skin flaking, and it can bleach clothing, towels, bedding, and hair.
Topical antibiotics — Topical antibiotics (creams or liquids) control the growth of acne bacteria and reduce inflammation. Topical antibiotics include erythromycin, clindamycin, sulfacetamide, and dapsone.
Moderate to severe inflammatory acne — For people with moderate to severe inflammatory acne (picture 3), oral antibiotics or an oral retinoid known as isotretinoin (Amnesteem, Claravis, Sotret, Absorica) may be recommended. Topical medication may be used in combination with oral antibiotics.
Women often benefit from hormonal treatment with a birth control pill. (See 'Hormone therapy' below.)
Oral antibiotics — Oral antibiotics work to slow the growth of acne-producing bacteria. However, oral antibiotics can have bothersome side effects, including vaginal yeast infections in women and stomach upset.
Doxycycline and minocycline are the most commonly prescribed oral antibiotics for acne. They cannot be used during pregnancy or in children less than nine years of age.
Oral isotretinoin — Oral isotretinoin (Amnesteem, Claravis, Sotret, Absorica) is a potent retinoid medication that is extremely effective in the treatment of severe acne. It cures or significantly improves acne in the majority of patients. Oral isotretinoin is effective in treating the most disfiguring types of acne (see "Oral isotretinoin therapy for acne vulgaris"). Isotretinoin used to be sold as Accutane, but that brand name is no longer available.
Oral isotretinoin is usually taken in pill form once or twice daily with food for 20 weeks, then stopped. In some cases, acne can initially worsen before it improves. To reduce the risk for this initial flare of acne, isotretinoin is sometimes given at a lower dose for the first month of treatment. After treatment is stopped, improvement can continue for up to five months.
Side effects and risks — Despite its positive effects, oral isotretinoin can have serious side effects and should be used with caution. Taking isotretinoin during pregnancy can cause miscarriage and life-threatening malformations in the baby. For these reasons, there are strict rules in the United States for healthcare providers, pharmacists, and patients regarding the use and prescription of oral isotretinoin. Prescriptions of isotretinoin are regulated by the iPLEDGE program (www.ipledgeprogram.com), which requires the following:
●All women must have two negative pregnancy tests before receiving a prescription, and then they must have monthly pregnancy tests throughout the course of treatment.
●Women who could become pregnant must fill their prescription within seven days of receiving it; after this time, a new prescription must be written.
●Any woman who is or might become sexually active with a male partner must use two forms of birth control for at least one month before starting therapy and continue until one month after stopping isotretinoin.
●Women who cannot become pregnant and men must also participate in iPLEDGE, but do not require pregnancy testing or use of birth control.
Information about oral isotretinoin can be found at the United States Food and Drug Administration web site, (www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm085227.htm).
A variety of non-pregnancy related side effects may occur during isotretinoin therapy:
●Dryness or peeling of skin, soreness and cracking of the lips, itching, muscle pain, nosebleeds, difficulty wearing contact lenses, and sensitivity to the sun may occur during treatment.
●There is concern about the relationship between isotretinoin and depression and suicidal behavior. While there is not enough evidence to conclude that it causes depression or suicidal behavior, patients taking isotretinoin should report any sadness, depression, or anxiety to their healthcare provider.
●Isotretinoin can cause increases in blood levels of triglycerides (fatty substances related to cholesterol), liver damage, pancreatitis, and changes in the blood counts. It is unclear whether isotretinoin treatment increases the risk for inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease.
While many of these side effects can be managed without stopping the drug, others can be dangerous and require that you immediately stop taking it. Stay in touch with your doctor, and follow instructions for getting regular blood tests to monitor cholesterol, triglycerides, liver function, and blood counts.
Hormone therapy — The hormone estrogen can help to offset the effect of androgens (hormones responsible for acne development). Estrogen treatment in the form of a birth control pill is sometimes recommended for women with moderate or severe acne. (See "Patient education: Hormonal methods of birth control (Beyond the Basics)".)
Not all oral contraceptives should be used for the treatment of acne; some can actually worsen acne. Certain types of intrauterine devices (IUDs) and some injectable forms of birth control also may worsen acne. Discuss the best options with your healthcare provider. (See "Hormonal therapy for women with acne vulgaris".)
Spironolactone is another medication that can be used to treat acne in women. Spironolactone reduces the effects of androgens.
The benefits of birth control pills and other hormonal medications may not be noticeable until three to six months after treatment is started. Treatment with hormonal medications is not recommended during pregnancy.
Acne and pregnancy — Many acne treatments are not safe for use during pregnancy. Women who are pregnant or intending to become pregnant should consider stopping all acne treatments before becoming pregnant. If acne therapy becomes necessary, discuss the options with your healthcare provider.
WHERE TO GET MORE INFORMATION
Your healthcare provider is the best source of information for questions and concerns related to your medical problem.
This article will be updated as needed on our web site (www.uptodate.com/patients). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.
Patient level information — UpToDate offers two types of patient education materials.
The Basics — The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.
Patient education: Acne (The Basics)
Patient education: Rosacea (The Basics)
Patient education: Normal sexual development (puberty) (The Basics)
Patient education: Keloids (The Basics)
Patient education: Sertoli-Leydig cell tumor (The Basics)
Beyond the Basics — Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.
Patient education: Polycystic ovary syndrome (PCOS) (Beyond the Basics)
Patient education: Sunburn prevention (Beyond the Basics)
Patient education: Hormonal methods of birth control (Beyond the Basics)
Professional level information — Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.
Light-based, adjunctive, and other therapies for acne vulgaris
Oral isotretinoin therapy for acne vulgaris
Pathogenesis, clinical manifestations, and diagnosis of acne vulgaris
Treatment of acne vulgaris
Hormonal therapy for women with acne vulgaris
The following organizations also provide reliable health information.
●American Academy of Dermatology
●National Library of Medicine
(www.nlm.nih.gov/medlineplus/acne.html, available in Spanish)
●National Institute of Arthritis and Musculoskeletal and Skin Diseases
(www.niams.nih.gov/Health_Info/Acne, available in Spanish and Chinese)
- Chiu A, Chon SY, Kimball AB. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch Dermatol 2003; 139:897.
- Haider A, Shaw JC. Treatment of acne vulgaris. JAMA 2004; 292:726.
- Shalita AR, Chalker DK, Griffith RF, et al. Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study. Cutis 1999; 63:349.
- Ozolins M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet 2004; 364:2188.
- Amichai B, Shemer A, Grunwald MH. Low-dose isotretinoin in the treatment of acne vulgaris. J Am Acad Dermatol 2006; 54:644.
All topics are updated as new information becomes available. Our peer review process typically takes one to six weeks depending on the issue.